Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (509)	11/21/2001 2:35:42 PM
From: tuck	Read Replies (2) of 1005

BLUE H stock munches BLUE H stock, not something we see every day. And GNOM shareholders, who got nada for research premium, might not want to see another deal like that again, anyhow. OTOH, if GNOM had anything at all worth while, and EXEL can separate the wheat from the chaff . . . what a deal for them. Message 16681160 EXEL has closed a gap up to serious overhead resistance. I would expect it to weaken somewhat, and it might be worth a look when it does. Or perhaps GNOM is selling at a slight discount to the offer? I haven't yet looked. Message 16681160 Will put EXEL in the WatchList. Another way to play in Hell while we wait for fresh victims. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next